AL Amyloidosis — Trials

AL Amyloidosis — Trials · CancerIndex

Clinical trials

Registered studies

79 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04115956	A Clinical Study of Melphalan Flufenamide (Melflufen) and Dexamethasone for Patients With Immunoglobulin Light Chain (AL) Amyloidosis	terminated	Phase 1	6	Oncopeptides ABINDUSTRY	9	Mar 28, 2022	clinicaltrials
NCT03000660	Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis	terminated	Phase 1	3	Tufts Medical CenterOTHER	1	Aug 21, 2020	clinicaltrials